The consolidated FY2018-19 Q3 net profit decreased by Rs.1.31 Crore at Panache Digilife Limited as against the previous year.

Company : Par Drugs and Chemicals Limited

Panache Digilife Limited reported standalone fall of PAT by Rs.32.46 Lakh as against Rs.71.62 Lakh of FY2017-18 Q3.

By 31.12.2018, the standalone PAT was Rs.90.62 Lakh that is Rs.40.52 Lakh less against last year.

Following are the standalone fiscal details of Panache Digilife Limited:

- In FY2018-19 the company earned standalone revenue of Rs.16.49 Crore in Q3 which is Rs.1.26 Crore less than previous year.
- The PBT in Q3 of FY18-19 stood at Rs.58.98 Lakh which was Rs.12.64 Lakh more in the previous year.
- After 9 month end of FY2018-19, the PBT margin decreased by Rs.0.38 Lakh as compared to FY2017-18.
- The PBT was Rs.3.70 Crore on 31.3.18 and PAT stood at Rs.2.35 Crore

Below mentioned is the consolidated financial status of Panache Digilife Limited:

- The consolidated earning of Panache Digilife Limited in Q3 FY18-19 was Rs.16.49 Crore that is Rs.11.38 Crore lower than last year.
- At the 9 month end the earning decreased by Rs.11.66 Crore as against FY2017-18.
- The final revenue of FY2017 was Rs.103.32 Crore with PBT of Rs.6.08 Crore and Net profit of Rs.4.80 Crore.
- In FY2018-19 the PBT was of Rs.55.37 Lakh in Q3 whereas in previous year it was Rs.1.67 Crore.
- After 9 month end of FY2018-19, PBT was Rs.1.12 Crore which was Rs.2.16 Crore last year.
- After 31.12.2017 the PAT was Rs.2.16 Crore which was Rs.1.43 Crore more than current fiscal year.

Panache Digilife Limited is an ISO 9001:2015 certified company based in Mumbai. The Company is a leader in ICT & loT devices and solutions.

Recent Stories